查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1411705

数位生物标记市场：按类型、治疗领域、最终用途分类 - 2024-2030 年全球预测

Digital Biomarkers Market by Type (Hardware, Software), Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Musculoskeletal disorders, Neurological disorders), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年数位生物标记市场规模为36.3亿美元，2024年将达43.4亿美元，2030年将达到130亿美元，复合年增长率为19.97%。

数位生物标誌物的全球市场

主要市场统计
基准年[2023] 36.3亿美元
预测年份 [2024] 43.4亿美元
预测年份 [2030] 130亿美元
复合年增长率（%） 19.97%
数位生物标记市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估数位生物标记市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对数位生物标记市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-数位生物标记物市场的市场规模和预测是多少？

2-在数位生物标记市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-数位生物标记市场的技术趋势和法律规范是什么？

4-数位生物标记市场主要供应商的市场占有率是多少？

5-进入数位生物标记市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 在慢性病治疗中增加生物标记检测的使用
      • 数位生物标记诊断的主要好处
      • 数位生物标记在以病人为中心的药物开发和精准医疗的应用
    • 抑制因素
      • 与生物标记物开发和数位生物标记物采用相关的高成本
    • 机会
      • 数位生物标誌物的最新进展提高了弹性和定製配置
      • 政府对远端医疗基础设施的投资
    • 任务
      • 与资料检验和解释相关的问题
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章数位生物标记市场：按类型

  • 硬体
    • 感应器
    • 穿戴式装置
  • 软体

第 7 章按治疗领域分類的数位生物标记市场

  • 心血管和代谢疾病（CVMD）
  • 肌肉骨骼疾病
  • 神经系统疾病
  • 精神障碍
  • 呼吸系统疾病
  • 睡眠和运动障碍

第八章数位生物标记市场：依最终用途

  • 医疗保健消费者
  • 医疗服务提供方

第九章美洲数位生物标记市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区数位生物标记市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的数位生物标记市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • ActiGraph, LLC
    • Adherium
    • Akili, Inc.
    • Altoida, Inc.
    • Amgen Inc.
    • Aural Analytics, Inc.
    • Biofourmis Pte. Ltd.
    • Biogen Inc.
    • Brainomix
    • Chugai Pharmaceutical Co., Ltd.
    • Clarigent Health
    • Eli Lilly and Company
    • Empatica Inc.
    • F. Hoffmann-La Roche Ltd.
    • Feel Therapeutics
    • GERO PTE. LTD.
    • Huma Therapeutics Limited
    • IXICO PLC
    • Kinsa Inc.
    • Koneksa Health
    • Medable Inc.
    • Owkin, Inc.
    • Sidekick Health ehf.
    • Verily Life Sciences
    • VivoSense, Inc
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-5C6F41F5AF53

[192 Pages Report] The Digital Biomarkers Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 4.34 billion in 2024, at a CAGR 19.97% to reach USD 13.00 billion by 2030.

Global Digital Biomarkers Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.63 billion
Estimated Year [2024] USD 4.34 billion
Forecast Year [2030] USD 13.00 billion
CAGR (%) 19.97%
Digital Biomarkers Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Biomarkers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Biomarkers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Digital Biomarkers Market, highlighting leading vendors and their innovative profiles. These include ActiGraph, LLC, Adherium, Akili, Inc., Altoida, Inc., Amgen Inc., Aural Analytics, Inc., Biofourmis Pte. Ltd., Biogen Inc., Brainomix, Chugai Pharmaceutical Co., Ltd., Clarigent Health, Eli Lilly and Company, Empatica Inc., F. Hoffmann-La Roche Ltd., Feel Therapeutics, GERO PTE. LTD., Huma Therapeutics Limited, IXICO PLC, Kinsa Inc., Koneksa Health, Medable Inc., Owkin, Inc., Sidekick Health ehf., Verily Life Sciences, and VivoSense, Inc.

Market Segmentation & Coverage

This research report categorizes the Digital Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hardware
      • Sensor
      • Wearable Device
    • Software
  • Therapeutic Area
    • Cardiovascular and metabolic disorders (CVMD)
    • Musculoskeletal disorders
    • Neurological disorders
    • Psychiatric Disorders
    • Respiratory Disorders
    • Sleep & Movement Disease
  • End-Use
    • Healthcare Consumers
    • Healthcare Providers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Digital Biomarkers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Biomarkers Market?

3. What are the technology trends and regulatory frameworks in the Digital Biomarkers Market?

4. What is the market share of the leading vendors in the Digital Biomarkers Market?

5. Which modes and strategic moves are suitable for entering the Digital Biomarkers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Digital Biomarkers Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing usage of biomarkers testing for the treatment of chronic diseases
      • 5.1.1.2. Significant benefits of digital biomarkers diagnosis
      • 5.1.1.3. Applications of digital biomarkers in patient-focused drug development and precision medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with biomarkers development and adoption of digital biomarkers
    • 5.1.3. Opportunities
      • 5.1.3.1. Recent advancements in digital biomarkers for more flexibility and customized configuration
      • 5.1.3.2. Government investment in telehealth infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with data validation and interpretation
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Digital Biomarkers Market, by Type

  • 6.1. Introduction
  • 6.2. Hardware
    • 6.3.1. Sensor
    • 6.3.2. Wearable Device
  • 6.3. Software

7. Digital Biomarkers Market, by Therapeutic Area

  • 7.1. Introduction
  • 7.2. Cardiovascular and metabolic disorders (CVMD)
  • 7.3. Musculoskeletal disorders
  • 7.4. Neurological disorders
  • 7.5. Psychiatric Disorders
  • 7.6. Respiratory Disorders
  • 7.7. Sleep & Movement Disease

8. Digital Biomarkers Market, by End-Use

  • 8.1. Introduction
  • 8.2. Healthcare Consumers
  • 8.3. Healthcare Providers

9. Americas Digital Biomarkers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Biomarkers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Biomarkers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. ActiGraph, LLC
    • 13.1.2. Adherium
    • 13.1.3. Akili, Inc.
    • 13.1.4. Altoida, Inc.
    • 13.1.5. Amgen Inc.
    • 13.1.6. Aural Analytics, Inc.
    • 13.1.7. Biofourmis Pte. Ltd.
    • 13.1.8. Biogen Inc.
    • 13.1.9. Brainomix
    • 13.1.10. Chugai Pharmaceutical Co., Ltd.
    • 13.1.11. Clarigent Health
    • 13.1.12. Eli Lilly and Company
    • 13.1.13. Empatica Inc.
    • 13.1.14. F. Hoffmann-La Roche Ltd.
    • 13.1.15. Feel Therapeutics
    • 13.1.16. GERO PTE. LTD.
    • 13.1.17. Huma Therapeutics Limited
    • 13.1.18. IXICO PLC
    • 13.1.19. Kinsa Inc.
    • 13.1.20. Koneksa Health
    • 13.1.21. Medable Inc.
    • 13.1.22. Owkin, Inc.
    • 13.1.23. Sidekick Health ehf.
    • 13.1.24. Verily Life Sciences
    • 13.1.25. VivoSense, Inc
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DIGITAL BIOMARKERS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL BIOMARKERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. DIGITAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DIGITAL BIOMARKERS MARKET DYNAMICS
  • FIGURE 7. DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 10. DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DIGITAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. DIGITAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL BIOMARKERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. DIGITAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 8. DIGITAL BIOMARKERS MARKET SIZE, BY SENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 12. DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR AND METABOLIC DISORDERS (CVMD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DIGITAL BIOMARKERS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DIGITAL BIOMARKERS MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DIGITAL BIOMARKERS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DIGITAL BIOMARKERS MARKET SIZE, BY SLEEP & MOVEMENT DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. DIGITAL BIOMARKERS MARKET SIZE, BY HEALTHCARE CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DIGITAL BIOMARKERS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. DIGITAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 190. DIGITAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DIGITAL BIOMARKERS MARKET LICENSE & PRICING